These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2837231)

  • 21. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
    Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the mechanism of action of A80915A, a semi-naphthoquinone natural product, as an inhibitor of gastric (H(+)-K+)-ATPase.
    Dantzig AH; Minor PL; Garrigus JL; Fukuda DS; Mynderse JS
    Biochem Pharmacol; 1991 Oct; 42(10):2019-26. PubMed ID: 1683772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of gastric H+, K+-ATPase by 3-amino-5-methyl-2-(2-methyl-3-thienyl)imidazo[1,2-a]thieno[3,2-c]pyrid ine, SPI-447.
    Ushiro T; Tsukimi Y; Tanaka H
    Jpn J Pharmacol; 1997 Nov; 75(3):303-6. PubMed ID: 9434264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformation-dependent inhibition of gastric H+,K+-ATPase by SCH 28080 demonstrated by mutagenesis of glutamic acid 820.
    Swarts HG; Hermsen HP; Koenderink JB; Willems PH; de Pont JJ
    Mol Pharmacol; 1999 Mar; 55(3):541-7. PubMed ID: 10051539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
    Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
    J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of tannic acid on gastric H+,K(+)-ATPase.
    Murakami S; Muramatsu M; Otomo S
    J Nat Prod; 1992 Apr; 55(4):513-6. PubMed ID: 1324983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K+-stimulated p-nitrophenyl phosphatase is not a partial reaction of the gastric (H+ + K+)-transporting ATPase. Evidence supporting a new model for the univalent-cation-transporting ATPase systems.
    Ray TK; Nandi J
    Biochem J; 1986 Jan; 233(1):231-8. PubMed ID: 3006658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoaffinity labeling of the lumenal K+ site of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Fallowfield C; Lawrie KM; Saunders D; Richardson S; Ife RJ
    J Biol Chem; 1989 Apr; 264(10):5552-8. PubMed ID: 2925619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ouabain-insensitive, vanadate-sensitive K(+)-ATPase of rat distal colon is partly similar to gastric H+,K(+)-ATPase.
    Tabuchi Y; Takeguchi M; Asano S; Takeguchi N
    Jpn J Physiol; 1992; 42(4):577-89. PubMed ID: 1335523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of (H+ + K+)-ATPase and H+ accumulation in hog gastric membranes by trifluoperazine, verapamil and 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate.
    Im WB; Blakeman DP; Mendlein J; Sachs G
    Biochim Biophys Acta; 1984 Feb; 770(1):65-72. PubMed ID: 6320882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ro 18-5364, a potent new inhibitor of the gastric (H+ + K+)-ATPase.
    Sigrist-Nelson K; Krasso A; Müller RK; Fischli AE
    Eur J Biochem; 1987 Jul; 166(2):453-9. PubMed ID: 3038541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism for inhibition of gastric (H+ + K+)-ATPase by omeprazole.
    Lorentzon P; Eklundh B; Brändström A; Wallmark B
    Biochim Biophys Acta; 1985 Jul; 817(1):25-32. PubMed ID: 2988621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mechanism of action of omeprazole.
    Keeling DJ; Fallowfield C; Milliner KJ; Tingley SK; Ife RJ; Underwood AH
    Biochem Pharmacol; 1985 Aug; 34(16):2967-73. PubMed ID: 2992525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of gastric H+, K(+)-ATPase by chalcone derivatives, xanthoangelol and 4-hydroxyderricin, from Angelica keiskei Koidzumi.
    Murakami S; Kijima H; Isobe Y; Muramatsu M; Aihara H; Otomo S; Baba K; Kozawa M
    J Pharm Pharmacol; 1990 Oct; 42(10):723-6. PubMed ID: 1982146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational analysis of putative SCH 28080 binding sites of the gastric H+,K+-ATPase.
    Asano S; Matsuda S; Tega Y; Shimizu K; Sakamoto S; Takeguchi N
    J Biol Chem; 1997 Jul; 272(28):17668-74. PubMed ID: 9211917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of light and heavy vesicles simultaneously prepared from hog gastric mucosae.
    Asano S; Iino T; Tabuchi Y; Takeguchi N
    J Biochem; 1988 Apr; 103(4):672-7. PubMed ID: 2844740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [125I]azidosalicylyl melittin binding domains: evidence for a polypeptide receptor on the gastric (H+ + K+)ATPase.
    Cuppoletti J
    Arch Biochem Biophys; 1990 May; 278(2):409-15. PubMed ID: 2158280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The specificity of omeprazole as an (H+ + K+)-ATPase inhibitor depends upon the means of its activation.
    Keeling DJ; Fallowfield C; Underwood AH
    Biochem Pharmacol; 1987 Feb; 36(3):339-44. PubMed ID: 3028428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversible inhibitions of gastric H+,K(+)-ATPase by scopadulcic acid B and diacetyl scopadol. New biochemical tools of H+,K(+)-ATPase.
    Asano S; Mizutani M; Hayashi T; Morita N; Takeguchi N
    J Biol Chem; 1990 Dec; 265(36):22167-73. PubMed ID: 2176205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.